JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.14% |
| 2 | Technology | 13.12% |
| 3 | Financials | 12.1% |
| 4 | Healthcare | 9.54% |
| 5 | Consumer Discretionary | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Williams Companies
WMB
$88.9B
| $573M | 0.11% |
24,167,492
+1,012,509
| +4% | +$23.2M |
2013 Q2
26 quarters
|
|
202
Boston Properties
BXP
$9.43B
| $569M | 0.11% |
4,125,776
-10,331
| -0.2% | -$1.39M |
2013 Q2
26 quarters
|
|
203
Citizens Financial Group
CFG
$26.8B
| $566M | 0.11% |
13,942,973
-1,070,378
| -7% | -$40.1M |
2014 Q3
21 quarters
|
|
204
Vertex Pharmaceuticals
VRTX
$129B
| $566M | 0.11% |
2,585,389
-788,425
| -23% | -$160M |
2013 Q2
26 quarters
|
|
205
Vanguard Information Technology ETF
VGT
$157B
| $558M | 0.1% |
18,241,880
+1,707,192
| +10% | +$48.9M |
2014 Q2
22 quarters
|
|
206
Vanguard Financials ETF
VFH
$12.8B
| $556M | 0.1% |
7,290,512
+1,301,430
| +22% | +$95M |
2015 Q2
18 quarters
|
|
207
Invesco QQQ Trust
QQQ
$507B
| $556M | 0.1% |
2,615,588
-1,380,121
| -35% | -$276M |
2013 Q2
26 quarters
|
|
208
VF Corp
VFC
$5.9B
| $550M | 0.1% |
5,518,516
+166,946
| +3% | +$15M |
2013 Q2
26 quarters
|
|
209
Simon Property Group
SPG
$64.5B
| $549M | 0.1% |
3,685,600
+410,448
| +13% | +$61.5M |
2013 Q2
26 quarters
|
|
210
Shopify
SHOP
$220B
| $548M | 0.1% |
13,794,090
-4,859,260
| -26% | -$164M |
2015 Q2
18 quarters
|
|
211
Huazhu Hotels Group
HTHT
$13.9B
| $548M | 0.1% |
13,668,111
+133,092
| +1% | +$4.8M |
2017 Q2
10 quarters
|
|
212
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
| $542M | 0.1% |
10,077,183
-368,503
| -4% | -$19M |
2014 Q1
23 quarters
|
|
213
Huntington Bancshares
HBAN
$31B
| $541M | 0.1% |
35,871,655
+653,240
| +2% | +$9.58M |
2013 Q2
26 quarters
|
|
214
EPAM Systems
EPAM
$5.84B
| $541M | 0.1% |
2,547,997
+118,992
| +5% | +$23.4M |
2013 Q3
25 quarters
|
|
215
Fortune Brands Innovations
FBIN
$4.66B
| $529M | 0.1% |
9,476,259
-734,908
| -7% | -$38.7M |
2013 Q2
26 quarters
|
|
216
Ametek
AME
$57B
| $529M | 0.1% |
5,305,527
+183,782
| +4% | +$17.4M |
2013 Q2
26 quarters
|
|
|
ALXN
217
DELISTED
Alexion Pharmaceuticals
ALXN
| $528M | 0.1% |
4,879,339
+115,109
| +2% | +$12.3M |
2013 Q2
26 quarters
|
|
|
AGN
218
DELISTED
Allergan plc
AGN
| $526M | 0.1% |
2,748,935
-2,849,421
| -51% | -$514M |
2013 Q2
26 quarters
|
|
|
WCN
219
Waste Connections
WCN
$38.4B
| $525M | 0.1% |
5,783,887
-2,189,415
| -27% | -$199M |
2013 Q2
26 quarters
|
|
220
TC Energy
TRP
$62.6B
| $521M | 0.1% |
9,773,744
+423,539
| +5% | +$21.7M |
2013 Q2
26 quarters
|
|
221
Eastman Chemical
EMN
$7.17B
| $517M | 0.1% |
6,518,351
+169,665
| +3% | +$13M |
2013 Q2
26 quarters
|
|
222
Generac Holdings
GNRC
$13.3B
| $515M | 0.1% |
5,122,395
+78,169
| +2% | +$7.28M |
2013 Q2
26 quarters
|
|
223
iShares Russell 1000 Growth ETF
IWF
$130B
| $515M | 0.1% |
11,701,108
-448,120
| -4% | -$18.7M |
2013 Q2
26 quarters
|
|
224
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $511M | 0.1% |
9,534,762
+2,194,042
| +30% | +$118M |
2013 Q2
26 quarters
|
|
225
Intercontinental Exchange
ICE
$87.7B
| $511M | 0.1% |
5,519,972
-2,192,792
| -28% | -$204M |
2013 Q2
26 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.